淄博万昌科技股份有限公司 2014 年第三季度报告全文 淄博万昌科技股份有限公司 2014 年第三季度报告 2014 年 10 月 1 淄博万昌科技股份有限公司 2014 年第三季度报告全文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存在虚 假记载、误导性陈述或者重大遗漏，并承担个别和连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人于秀媛、主管会计工作负责人孙铭娟及会计机构负责人(会计主管人员)于文杰声明：保证 季度报告中财务报表的真实、准确、完整。 2 淄博万昌科技股份有限公司 2014 年第三季度报告全文 第二节 主要财务数据及股东变化 一、主要会计数据和财务指标 公司是否因会计政策变更及会计差错更正等追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期末 | 上年度末 | | 本报告期末比上年度末增减 | | --- | --- | --- | --- | --- | | 总资产（元） | 766,086,032.00 | 773,799,469.63 | | -1.00% | | 归属于上市公司股东的净资产 ...

淄博万昌科技股份有限公司 2014 年第三季度报告正文 证券代码：002581 证券简称：万昌科技 公告编号：2014-067 淄博万昌科技股份有限公司 2014 年第三季度报告正文 1 第一节 重要提示 淄博万昌科技股份有限公司 2014 年第三季度报告正文 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存在虚 假记载、误导性陈述或者重大遗漏，并承担个别和连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人于秀媛、主管会计工作负责人孙铭娟及会计机构负责人(会计主管人员)于文杰声明：保证 季度报告中财务报表的真实、准确、完整。 2 淄博万昌科技股份有限公司 2014 年第三季度报告正文 第二节 主要财务数据及股东变化 一、主要会计数据和财务指标 公司是否因会计政策变更及会计差错更正等追溯调整或重述以前年度会计数据 3 □ 是 √ 否 | | 本报告期末 | 上年度末 | | 本报告期末比上年度末增减 | | --- | --- | --- | --- | --- | | 总资产（元） | 766,086,032.00 | 773,799,469.63 ...

Financial Performance - The company achieved operating revenue of CNY 173,959,190.68, representing a year-on-year increase of 15.99%[19] - The net profit attributable to shareholders was CNY 51,167,335.04, up 11.15% compared to the same period last year[19] - The net cash flow from operating activities reached CNY 51,041,469.61, reflecting a significant increase of 26.85% year-on-year[19] - Operating costs increased by 26.54% to ¥103,013,516.15, primarily driven by the rise in product sales[27] - The company achieved a net profit of ¥5,116.73 million, reflecting an 11.15% year-on-year growth, with sales growth outpacing profit growth due to market competition[29] - The net profit attributable to shareholders for the period from January to September 2014 is expected to be between CNY 65.70 million and CNY 78.84 million, representing a growth of 0.00% to 20.00% compared to the same period in 2013[51] Asset and Equity Changes - Total assets at the end of the reporting period were CNY 765,961,105.41, a decrease of 1.01% from the previous year-end[19] - The net assets attributable to shareholders decreased by 2.60% to CNY 719,092,656.11 compared to the previous year-end[19] - The total owner's equity at the end of the period was CNY 719,092,650.00, reflecting changes in retained earnings and other components[117] - The total assets at the end of the reporting period amounted to RMB 696,303,110.00[119] Investment and Development - The company is actively planning major asset restructuring to enhance core competitiveness and profitability[24] - The expansion project for the production of dimethyl formamide and diethyl formamide has successfully entered trial production[24] - The company plans to continue focusing on new product development and market expansion in response to industry demand[24] - The company has committed a total investment of CNY 21,900 million, with an actual investment of CNY 24,408 million, achieving 89.25% of the planned investment progress by June 30, 2014[45] - The technical center upgrade project has completed the delivery of the R&D building and related facilities, with the pilot workshop currently under construction[46] Cash Flow and Financing - The net cash flow from operating activities increased by 26.85% to ¥51,041,469.61, attributed to reduced cash payments[28] - The total cash inflow from operating activities amounted to CNY 157,230,375.27, while cash outflow was CNY 106,188,905.66, resulting in a net increase of CNY 51,041,469.61[112] - The net cash flow from investing activities was -CNY 8,181,805.77, showing an improvement from -CNY 21,130,275.78 in the previous period[113] - The net cash flow from financing activities was -CNY 57,796,239.66, compared to -CNY 39,561,923.43 in the previous period[113] Shareholder Information - A total of 58,003,400 restricted shares held by shareholders were released from restrictions on May 20, 2014, including shares held by current directors[88] - Major shareholders included Gao Baolin with 23.47% (33,037,550 shares), Wang Suying with 15.22% (21,425,950 shares), and UAE Green Nile Commercial Company with 13.77% (19,383,500 shares)[93] - The total number of shareholders at the end of the reporting period was 8,893[93] Compliance and Governance - The governance structure of the company is compliant with relevant laws and regulations, ensuring the protection of shareholder rights[58] - The company has maintained a rigorous internal control system and management oversight during the reporting period[58] - The company has fulfilled all commitments made by major shareholders during the reporting period[78] - The company has maintained compliance with relevant regulatory requirements and internal management systems regarding related party transactions[80] Operational Challenges - The company has faced delays in project completion due to increased regulatory scrutiny and the need for new production equipment, impacting overall project timelines[46] - The company’s projects have not met the original completion timelines due to unforeseen technical and policy changes[45] Accounting and Financial Reporting - The company’s financial statements comply with the requirements of the Accounting Standards for Business Enterprises, reflecting true and complete financial conditions[129] - The company’s accounting year aligns with the calendar year, running from January 1 to December 31[130] - The financial report for the first half of 2014 has not been audited yet[81] - The company reported no issuance or conversion of preferred shares during the reporting period[97]

Financial Performance - The company's operating revenue for Q1 2014 was ¥86,097,696.65, representing a 15.5% increase compared to ¥74,545,216.83 in the same period last year[8] - Net profit attributable to shareholders was ¥26,520,405.70, up 19.01% from ¥22,283,616.10 year-on-year[8] - Basic earnings per share increased by 18.75% to ¥0.19, compared to ¥0.16 in the same period last year[8] - The net profit attributable to shareholders for the first half of 2014 is expected to increase by 10% to 30%, ranging from 50.64 million to 59.84 million CNY[25] - The net profit for the first half of 2013 was 46.03 million CNY, indicating a positive growth outlook for 2014[25] Cash Flow and Assets - The net cash flow from operating activities surged by 279.12% to ¥19,421,258.41, compared to ¥5,122,734.26 in the previous year[8] - Total assets at the end of the reporting period were ¥799,011,637.16, a 3.26% increase from ¥773,799,469.63 at the end of the previous year[8] - The company's net assets attributable to shareholders rose by 3.59% to ¥764,827,726.77 from ¥738,307,321.07 at the end of the previous year[8] - Cash received from sales increased by 45.51% compared to the previous period, primarily due to higher sales revenue and a smaller increase in accounts receivable[18] - Cash received from investment income increased, attributed to positive returns from government bond reverse repurchase investments, totaling 262,724.97 RMB for the reporting period[19] Expenses and Liabilities - Cash paid to employees rose by 53.77% compared to the previous period, mainly due to the payment of last year's unpaid sales commissions[18] - Taxes paid increased by 57.34% compared to the previous period, primarily due to higher VAT and corporate income tax payments[18] - Cash paid for the acquisition of fixed assets, intangible assets, and other long-term assets decreased by 68.82% compared to the previous period, mainly due to reduced investment in fundraising projects[18] - The company reported a 95.40% increase in business tax and additional fees due to prior year tax credits affecting current liabilities[17] Investments and Growth Strategies - Investment income increased as a result of positive returns from government bond reverse repurchase investments[17] - Other receivables increased by 108.00% due to the company advancing social insurance fees and housing fund for employees[16] - Fixed assets increased by 113.46% primarily due to the transfer of funds to fixed assets from fundraising projects[16] - The company has focused on market and customer demand, continuously reforming and improving its internal sales system[25] - There has been a year-on-year increase in the total production and sales volume of major products, achieving the operational goals of stabilizing prices, increasing volume, reducing costs, and enhancing efficiency[25]

Financial Performance - The company's operating revenue for 2013 was CNY 317,253,572.92, representing an increase of 11.18% compared to CNY 285,343,999.23 in 2012[21] - The net profit attributable to shareholders for 2013 was CNY 88,037,326.84, a 2.05% increase from CNY 86,270,938.32 in the previous year[21] - The net cash flow from operating activities increased by 31.88% to CNY 83,132,883.27, up from CNY 63,035,343.84 in 2012[21] - The total assets at the end of 2013 were CNY 773,799,469.63, reflecting a growth of 6.14% from CNY 729,024,996.83 at the end of 2012[21] - The net assets attributable to shareholders increased by 4.81% to CNY 738,307,321.07, compared to CNY 704,409,994.23 at the end of 2012[21] - The basic earnings per share for 2013 was CNY 0.63, a 3.28% increase from CNY 0.61 in 2012[21] - The weighted average return on equity for 2013 was 12.28%, slightly down from 12.78% in 2012[21] Market and Product Performance - Sales volume of main products, including dimethyl formamide and diethyl formate, reached 16,740 tons, up by 11.50% year-on-year[25] - The production yield of dimethyl formamide improved by 1.46 percentage points, while diethyl formate's yield increased by 1.87 percentage points compared to the previous year[26] - The company maintained a market share increase in key products, with total sales revenue from main business rising by 10.04% to 313,987,921.79 CNY[31] - The company has a total production capacity of 22,000 tons/year for its main products, which are the largest in China and among the major suppliers globally[48] - In 2013, the company achieved the best historical yield for its products, enhancing its competitive edge in the market[48] Research and Development - The company obtained 4 national invention patents during the reporting period, enhancing its core competitiveness[27] - The company is focusing on the development of key pharmaceutical and pesticide intermediates, benefiting from government support for technological innovation in the industry[58] - The company has established a provincial-level enterprise technology center and multiple research partnerships to accelerate innovation[48] Investment and Expansion - The company invested in significant fundraising projects, marking the largest investment scale since its establishment, with new facilities already in use[26] - The total amount of raised funds is 471.27 million RMB, with 14.86 million RMB utilized by the end of 2013[52] - The project for expanding production of original formic acid dimethyl ester and diethyl ester has reached an investment progress of 85.03%[55] - The expansion project for the original formic acid dimethyl ester/dimethyl ester is expected to enhance production capacity and product quality, with an additional investment of RMB 25.08 million from the raised funds[56] Risk Management - The company faces potential risks including stricter national safety and environmental policies and intensified market competition[11] - The company is actively adjusting its operational strategies to mitigate risks from intensified market competition and regulatory pressures on environmental standards[66] Shareholder and Dividend Information - The company plans to distribute a cash dividend of CNY 5.00 per 10 shares to all shareholders[4] - The cash dividend for 2013 represents 79.95% of the net profit attributable to shareholders, which is a significant increase compared to 62.76% in 2012 and 80.83% in 2011[77] - The total distributable profit for 2013 was 129,336,055.78 yuan, with remaining undistributed profits of 58,954,055.78 yuan carried forward to the next year[77] Corporate Governance - The company has not experienced any significant adverse effects on its production, financial status, or ongoing profitability[11] - The company has not faced any penalties or corrective actions during the reporting period[91] - The company has maintained a robust internal control system, with no incidents of insider trading reported during the period[130] Employee and Management Information - The company reported a total remuneration of 426.77 million CNY for directors, supervisors, and senior management in 2013, with an additional 10 million CNY from shareholder units[119] - As of December 31, 2013, the company employed a total of 228 staff, with 53.51% in production, 26.75% in technical roles, and 3.07% in sales[121] - The company has implemented a performance-based salary mechanism, ensuring that employee remuneration is linked to individual performance and company results[119] Financial Reporting and Compliance - The company adheres to the Chinese Accounting Standards, ensuring transparency and accuracy in its financial reporting[180] - The company has maintained a standard unqualified audit opinion for its financial statements[151] - The company has not reported any significant changes in its business operations or management structure in the last five years[114]